Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XLO | Common Stock | Conversion of derivative security | +666K | 666K | Oct 26, 2021 | See footnotes | F1, F3, F4 | |||
transaction | XLO | Common Stock | Conversion of derivative security | +151K | +22.73% | 817K | Oct 26, 2021 | See footnotes | F2, F3, F4 | ||
transaction | XLO | Common Stock | Purchase | $5M | +313K | +38.25% | $16.00 | 1.13M | Oct 26, 2021 | See footnotes | F3, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XLO | Series B Preferred Stock | Conversion of derivative security | -6.32M | -100% | 0 | Oct 26, 2021 | Common Stock | 666K | See footnotes | F1, F3, F4 | |||
transaction | XLO | Series C Preferred Stock | Conversion of derivative security | -1.44M | -100% | 0 | Oct 26, 2021 | Common Stock | 151K | See footnotes | F2, F3, F4 |
Bay City Capital Llc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date. |
F2 | The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date. |
F3 | Bay City Capital LLC, a Delaware limited liability company (BCC), Bay City Capital JV Management I LLC, a Delaware limited liability company (Management I), Bay City Capital GF XINDE Investment Management Co., a Cayman Islands company (Management Co.), and Bay City Capital GF Xinde International Life Sciences USD Fund, L.P., a Cayman Islands exempt limited partnership (USD Fund) are deemed to be a group for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management Co. is the general partner of USD Fund and has voting and dispositive power with respect to the securities held by USD Fund. BCC is the manager of, and an advisor to, Management I, and Management I holds an equity interest in Management Co. |
F4 | Represent securities held by USD Fund, including indirect interests of BCC, Management I, and Management Co. BCC, Management I and Management Co. each disclaims beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein. |